150 related articles for article (PubMed ID: 30104738)
21. [High-throughput functional screening using CRISPR/Cas9 system].
Wang GC; Ming M; Ye YZ; Xi JZ
Yi Chuan; 2016 May; 38(5):391-401. PubMed ID: 27232487
[TBL] [Abstract][Full Text] [Related]
22. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
23. A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells.
Poulsen TT; Pedersen N; Juel H; Poulsen HS
Cancer Gene Ther; 2008 Sep; 15(9):563-75. PubMed ID: 18421308
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9-based photoactivatable transcription system.
Nihongaki Y; Yamamoto S; Kawano F; Suzuki H; Sato M
Chem Biol; 2015 Feb; 22(2):169-74. PubMed ID: 25619936
[TBL] [Abstract][Full Text] [Related]
25. A novel luciferase knock-in reporter system for studying transcriptional regulation of the human Sox2 gene.
Xiao D; Zhang W; Li Y; Liu K; Zhao J; Sun X; Shan L; Mao Q; Xia H
J Biotechnol; 2016 Feb; 219():110-6. PubMed ID: 26721181
[TBL] [Abstract][Full Text] [Related]
26. Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model.
Xu Q; Junttila S; Scherer A; Giri KR; Kivelä O; Skovorodkin I; Röning J; Quaggin SE; Marti HP; Shan J; Samoylenko A; Vainio SJ
Dis Model Mech; 2017 Dec; 10(12):1503-1515. PubMed ID: 29084770
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
[TBL] [Abstract][Full Text] [Related]
28. Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening.
Picco G; Chen ED; Alonso LG; Behan FM; Gonçalves E; Bignell G; Matchan A; Fu B; Banerjee R; Anderson E; Butler A; Benes CH; McDermott U; Dow D; Iorio F; Stronach E; Yang F; Yusa K; Saez-Rodriguez J; Garnett MJ
Nat Commun; 2019 May; 10(1):2198. PubMed ID: 31097696
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.
Haviv YS; van Houdt WJ; Lu B; Curiel DT; Zhu ZB
Mol Cancer Ther; 2004 Jun; 3(6):687-91. PubMed ID: 15210854
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice.
Weber J; Öllinger R; Friedrich M; Ehmer U; Barenboim M; Steiger K; Heid I; Mueller S; Maresch R; Engleitner T; Gross N; Geumann U; Fu B; Segler A; Yuan D; Lange S; Strong A; de la Rosa J; Esposito I; Liu P; Cadiñanos J; Vassiliou GS; Schmid RM; Schneider G; Unger K; Yang F; Braren R; Heikenwälder M; Varela I; Saur D; Bradley A; Rad R
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13982-7. PubMed ID: 26508638
[TBL] [Abstract][Full Text] [Related]
31. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
32. Molecular profiling of renal cancer: the journey to clinical application.
Ribal MJ
Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
[No Abstract] [Full Text] [Related]
33. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
34. Kidney cancer: Programmed death ligand 1 regulation in ccRCC.
Stone L
Nat Rev Urol; 2016 Feb; 13(2):65. PubMed ID: 26754191
[No Abstract] [Full Text] [Related]
35. Microarray gene expression profiling and analysis in renal cell carcinoma.
Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
[TBL] [Abstract][Full Text] [Related]
36. Identifying novel candidate biomarkers of RCC based on WGCNA analysis.
Deng J; Kong W; Mou X; Wang S; Zeng W
Per Med; 2018 Sep; 15(5):381-394. PubMed ID: 30259787
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
[TBL] [Abstract][Full Text] [Related]
38. Gene Editing to Generate Versatile Human Pluripotent Stem Cell Reporter Lines for Analysis of Differentiation and Lineage Tracing.
Bao X; Adil MM; Muckom R; Zimmermann JA; Tran A; Suhy N; Xu Y; Sampayo RG; Clark DS; Schaffer DV
Stem Cells; 2019 Dec; 37(12):1556-1566. PubMed ID: 31634414
[TBL] [Abstract][Full Text] [Related]
39.
Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
[TBL] [Abstract][Full Text] [Related]
40. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice.
Aida T; Chiyo K; Usami T; Ishikubo H; Imahashi R; Wada Y; Tanaka KF; Sakuma T; Yamamoto T; Tanaka K
Genome Biol; 2015 Apr; 16(1):87. PubMed ID: 25924609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
